Cargando…
Utilization of myositis antibody-specific panel for diagnosis, treatment, and evaluation of disease progression
The idiopathic inflammatory myopathies (IIM) are rare sporadic disorders with an overall annual incidence of approximately 1 in 100,000 and with a higher incidence in women. IIM is an autoimmune process leading to muscle inflammation due to a ‘dysfunctional adaptive immune response evidenced by cell...
Autores principales: | Stark, Ana, Hauptman, Howard, Nguyen, Binh, Mathew, Minu, Aversano, Alexander, Mueller, Jerrica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671718/ https://www.ncbi.nlm.nih.gov/pubmed/33235684 http://dx.doi.org/10.1080/20009666.2020.1793478 |
Ejemplares similares
-
Myositis-specific Antibodies: Overview and Clinical Utilization
por: Halilu, Fatima, et al.
Publicado: (2022) -
Clinical Significance of Myositis-Specific and Myositis-Associated Antibody Profiles in Dermatomyositis
por: Babu, Anuradha K., et al.
Publicado: (2022) -
External Validation and Evaluation of Adding MRI or Extended Myositis Antibody Panel to the 2017 EULAR/ACR Myositis Classification Criteria
por: Luu, Queenie, et al.
Publicado: (2019) -
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study
por: Sambataro, Gianluca, et al.
Publicado: (2023) -
The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients
por: Negalur, Natasha Vijay, et al.
Publicado: (2021)